• SB 431542: ALK5 Inhibitor for TGF-β Pathway Research Excelle

  2026-04-30

  SB 431542, a highly selective ALK5 inhibitor from APExBIO, empowers researchers to dissect TGF-β-dependent mechanisms with precision. Its proven performance in Smad2 pathway inhibition, anti-tumor immunity, and advanced fibrosis models sets a new standard for reproducible, data-driven workflows.

• DMH-1 (ALK2 Inhibitor): Unlocking Controlled Differentiation

  2026-04-29

  Explore how DMH1, a selective ALK2 inhibitor, empowers organoid and non-small cell lung cancer research by enabling precise modulation of cell fate and proliferation. This article uniquely bridges mechanistic insights with practical assay optimization for translational scientists.

• THZ1: Covalent CDK7 Inhibitor Benchmarks in T-ALL Research

  2026-04-29

  THZ1 is a potent, selective covalent CDK7 inhibitor with irreversible action and nanomolar efficacy in T-ALL models. Its unique mechanism involves covalent modification outside the kinase domain, driving robust transcription regulation inhibition. This article details evidence, workflows, and limitations for THZ1 in cancer biology.

• Lignans from Rosemary Roots: Novel Anti-Inflammatory Agents

  2026-04-28

  This study systematically isolated and characterized eight lignans and four phenylpropanoids from the roots of Rosmarinus officinalis, including three previously unknown compounds. Several of these lignans demonstrated potent, dose-dependent inhibition of nitric oxide production in LPS-stimulated macrophages, highlighting rosemary roots as a promising source of anti-inflammatory agents.

• 4-Phenylbutyric Acid: Optimizing ER Stress Assays in Cell Mo

  2026-04-28

  4-Phenylbutyric acid (4-PBA) from APExBIO sets the benchmark for reproducible endoplasmic reticulum (ER) stress modulation, enabling precise apoptosis and autophagy research. This article delivers actionable protocol enhancements, advanced troubleshooting, and real-world insights—bridging foundational studies and next-generation disease models.

• Baicalin and KEAP1-NRF2/HO-1 Pathway Modulation in Research

  2026-04-27

  Baicalin, a high-purity flavone glycoside from Scutellaria baicalensis, empowers researchers to precisely modulate KEAP1-NRF2/HO-1 and TGF-β1/p-Smad3 signaling in cutting-edge cancer and neuroplasticity studies. Its validated application in both ocular dominance plasticity and cancer sensitization sets a new standard for translational workflows.

• Cyclosporin: Mechanistic Precision in Translational Immunolo

  2026-04-27

  This article delivers a mechanistic and strategic synthesis for translational researchers using Cyclosporin A. It dissects the role of cyclophilin A in immunosuppression, contextualizes experimental design with evidence-backed protocol guidance, and positions APExBIO’s Cyclosporin as a research-grade benchmark. Bridging foundational biology with translational impact, it provides a nuanced, evidence-labeled roadmap for immunology and mitochondrial research.

• CHIR-99021 (CT99021): Optimizing Stem Cell Differentiation W

  2026-04-26

  CHIR-99021 (CT99021) is a benchmark GSK-3 inhibitor, enabling precise Wnt/β-catenin pathway control for robust stem cell applications. Leveraging new 3D neurovascular co-culture insights and best practices, researchers can now streamline differentiation protocols and troubleshoot common pitfalls with enhanced reproducibility.

• Mitochondrial IRF3 Links Mitophagy Disruption to Pulmonary F

  2026-04-25

  This study uncovers a novel mechanism in which mitochondrial IRF3 impairs mitophagy and induces ferroptosis in alveolar epithelial cells, driving pulmonary fibrosis progression. These findings highlight a new therapeutic target at the intersection of inflammation, mitochondrial quality control, and regulated cell death.

• PXR Activation Shields Against Cholestatic Liver Injury via

  2026-04-24

  This study demonstrates that activation of the pregnane X receptor (PXR) with pregnenolone-16α-carbonitrile protects against cholestatic liver injury in mice by suppressing both canonical and non-canonical hepatocyte pyroptosis. The findings uncover distinct anti-inflammatory pathways, positioning PXR as a high-value therapeutic target for cholestatic diseases.

• Bleomycin Sulfate Workflows: Pulmonary Fibrosis & DNA Damage

  2026-04-24

  Bleomycin Sulfate (Blenoxane) is the gold-standard tool for modeling DNA strand breaks and pulmonary fibrosis, enabling precise pathway interrogation in oncology and fibrotic research. This guide translates cutting-edge findings and vendor-supplied expertise into actionable protocols, troubleshooting strategies, and advanced use-cases for reproducible results.

• A 83-01: ALK-5 Inhibitor Transforming Organoid and EMT Resea

  2026-04-23

  A 83-01, a selective ALK-5 inhibitor from APExBIO, redefines experimental control in TGF-β signaling, organoid differentiation, and EMT modeling. Its nanomolar potency and robust Smad-dependent transcription suppression unlock reproducible, tunable protocols for high-diversity organoid systems and advanced disease modeling.

• Oral Faropenem Sodium: Resistance Risks and Research Implica

  2026-04-23

  This article reviews the reference study on oral faropenem sodium, highlighting its clinical utility, mechanisms, and implications for antimicrobial resistance (AMR). The findings emphasize the molecule's broad-spectrum efficacy, ease of oral administration, and the emerging threat of cross-resistance with other carbapenems—raising important considerations for responsible antibiotic use and translational infection research.

• Quercetin Modulates Hippo Pathway to Protect Cataract Lenses

  2026-04-22

  This study reveals that quercetin mitigates cataract formation by inactivating the Hippo signaling pathway, which enhances lens epithelial cell survival and reduces oxidative stress. The findings clarify a mechanistic link between Hippo pathway suppression and lens protection, supporting the pursuit of non-surgical cataract interventions.

• Super-Enhancer Hijacking of LINC01977 Drives Early LUAD via

  2026-04-22

  Zhang et al. reveal that super-enhancer (SE) hijacking of the lncRNA LINC01977 drives malignancy in early-stage lung adenocarcinoma (LUAD) through dependency on canonical TGF-β/Smad3 signaling. Their integrative approach uncovers a feedback loop involving tumor-associated macrophages, providing a potential new target for early intervention in LUAD progression.

16097 records 1/1074 page Next 12345 下5页 Last page